Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes

Biomaterials

Volumn 31, Issue 17, 2010, Pages 4757-4763

  Xu, Huan ^a   Wang, Kai Q ^b   Deng, Yi H ^b   Chen, Da W ^b  

^a LIAONING NORMAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATED BLOOD CLEARANCES; CIRCULATION TIME; IMMUNE RESPONSE; LIVER ACCUMULATION; PEGYLATED LIPOSOMES; TRISHYDROXYMETHYLAMINOMETHANE;

BLOOD; LIPOSOMES; LIVER; METHANOL; PHOSPHOLIPIDS;

POLYETHYLENE GLYCOLS;

CALCEIN; CHOLESTEROL DERIVATIVE; LIPOSOME; MACROGOL;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL BOND; CIRCULATION TIME; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG UPTAKE; LIVER; MALE; NONHUMAN; PARTICLE SIZE; PLASMA CLEARANCE; PRIORITY JOURNAL; RAT; SPLEEN; SURFACE PROPERTY;

ANIMALS; CHOLESTEROL; FLUORESCEINS; INJECTIONS; LIPOSOMES; MALE; POLYETHYLENE GLYCOLS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

RATTUS;

EID: 77951086240     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.049     Document Type: Article

References (32)

1. Lee R.J., Low P.S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1995, 1233:134-144.
2. Song L.Y., Ahkong Q.F., Rong Q., Wang Z., Ansell S., Hope M.J., et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 2002, 1558:1-13.
3. Wang J.P., Yoshie M., Kozo T., Tsuneji N. In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome. Int J Pharm 2000, 203:61-69.
4. Awasthi V.D., Garcia D., Coins B.A., Phillips W.T. Circulation and biodistribution profiles of long circulating PEG liposomes of various sizes in rabbits. Int J Pharm 2003, 253:121-132.
5. Dams E.T., Laverman P., Oyen W.J., Storm G., Scherphof G.L., Van Der Meer J.W., et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther 2000, 292:1071-1079.
6. Laverman P., Carstens M.G., Boerman O.C., Dams E.T., Oyen W.J., van Rooijen N., et al. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther 2001, 298:607-612.
7. Ishida T., Atobe K., Wang X.Y., Kiwada H. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. J Control Release 2006, 115:251-258.
8. Lu W., Wan J., She Z.J., Jiang X.G. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. J Control Release 2007, 118:38-53.
9. Ishihara T., Takeda M., Sakamoto H., Kimoto A., Kobayashi C., Takasaki N., et al. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles. Pharm Res 2009, 26:2270-2279.
10. Ishida T., Masuda K., Ichikawa T., Ichihara M., Irimura K., Kiwada H. Accelerated clearance of a second injection of PEGylated liposomes in mice. Int J Pharm 2003, 255:167-174.
11. Ishida T., Ichihara M., Wang X.Y., Yamamoto K., Kimura J., Majima E., et al. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release 2006, 112:15-25.
12. Ishida T., Ichihara M., Wang X.Y., Kiwada H. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. J Control Release 2006, 115:243-250.
13. Ambegia E., Ansell S., Cullis P., Heyes J., Palmer L., MacLachlan I. Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochim Biophys Acta 2005, 1669:155-163.
14. Webb M.S., Saxon D., Wong F.M., Lim H.J., Wang Z., Bally M.B., et al. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim Biophys Acta 1998, 1372:272-282.
15. Judge A., McClintock K., Phelps J.R., Maclachlan I. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. Mol Ther 2006, 13:328-337.
16. Semple S.C., Harasym T.O., Clow K.A., Ansell S.M., Klimuk S.K., Hope M.J. Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid. J Pharmacol Exp Ther 2005, 312:1020-1026.
17. Romberg B., Oussoren C., Snel C.J., Carstens M.G., Hennink W.E., Storm G. Pharmacokinetics of poly(hydroxyethyl-L-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration. Biochim Biophys Acta 2007, 1768:737-743.
18. Wang S.N., Deng Y.H., Wu H.B., Zhang L.L., Chen D.W. Assessment of the targetability of galactosylated liposomes to liver in mice. Chin Pharm J 2006, 41:1076-1079.
19. Xu H., Deng Y.H., Chen D.W., Hong W.W., Lu Y., Dong X.H. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives. J Control Release 2008, 130:238-245.
20. Clerc S., Barenholz Y. Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. Biochim Biophys Acta 1995, 1240:257-265.
21. Iden D.L., Allen T.M. In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta 2001, 1513:207-216.
22. Steenpass T., Lung A., Schubert R. Tresylated PEG-sterols for coupling of proteins to preformed plain or PEGylated liposomes. Biochim Biophys Acta 2006, 1758:20-28.
23. Visser C.C., Stevanović S., Voorwinden L.H., van Bloois L., Gaillard P.J., Danhof M., et al. Targeting liposomes with protein drugs to the blood-brain barrier in vitro. Eur J Pharm Sci 2005, 25:299-305.
24. Zheng J.Y., Huang H. Active drug-loaded and its research progress. Foreign Med Sci Section Pharm 2005, 32:271-274.
25. Zheng J.Y., Huang H., Zhang L. Preparation of tretinoin liposome by calcium acetate gradient method. China Pharm 2006, 17:579-581.
26. Huang S.L., Macdonald R.C. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta 2004, 1665:134-141.
27. Pavelić Z., Skalko-Basnet N., Schubert R., Jalsenjak I. Liposomal gels for vaginal drug delivery. Int J Pharm 2001, 219:139-149.
28. Ishida T., Ichikawa T., Ichihara M., Sadzuka Y., Kiwada H. Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice. J Control Release 2004, 95:403-412.
29. Goins B., Philips W.T., Klipper R. Repeat injection studies of technetium-99m-labeled PEG-liposomes in the same animal. J Liposome Res 1998, 8:265-281.
30. Ishida T., Harada M., Wang X.Y., Ichihara M., Irimura K., Kiwada H. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J Control Release 2005, 105:305-317.
31. Ishida T., Kashima S., Kiwada H. The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats. J Control Release 2008, 126:162-165.
32. Parr M.J., Ansell S.M., Choi L.S., Cullis P.R. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim Biophys Acta 1994, 1195:21-30.